Hims & Hers Stock Drops After Amazon Says It Will Offer Hair-Loss Treatments -- WSJ

Dow Jones04:15

By Jasmine Li

Shares of Hims & Hers slid after Amazon.com said it would offer cheap treatments for concerns like hair loss, skin care and erectile dysfunction, directly competing with the telehealth startup.

Amazon on Thursday launched the treatments through its One Medical telehealth service, and Amazon Prime members are eligible for free shipping, the company said.

Hims & Hers's stock is down 25% in Thursday trading. Shares have more than doubled this year, due in part to the company's introduction of weight-loss treatments in May. Amazon's online pharmacy partnered with Lilly in March to fill prescriptions for the weight-loss drug Zepbound.

Hims & Hers gained popularity as one of the first companies to directly ship hair and skin treatments to telehealth patients. The company said this month it had more than 2 million subscribers in the third quarter, a 40% boost from a year ago.

Amazon's push into low-cost treatments follows its launch of Haul, a budget online storefront similar to Temu or Shein.

Amazon said Prime members can access these treatments starting at:

-- Anti-aging skin-care: $10 a month

-- Men's hair loss: $16 a month

-- Erectile dysfunction treatment: $19 a month

-- Eyelash growth: $43 a month

-- Motion sickness treatment: $2 a month

This item is part of a Wall Street Journal live coverage event. The full stream can be found by searching P/WSJL (WSJ Live Coverage).

(END) Dow Jones Newswires

November 14, 2024 15:15 ET (20:15 GMT)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

judyspt
15:29
judyspt
Amazon wants to do everything will get backfire. Lost focus.

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2483331835?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-11-15 04:15","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2483331835","market":"other","top_or_hot":-1,"title":"Hims & Hers Stock Drops After Amazon Says It Will Offer Hair-Loss Treatments -- WSJ","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n       By Jasmine Li \n</p>\n<p>\n     Shares of Hims &amp; Hers slid after Amazon.com said it would offer cheap treatments for concerns like hair loss, skin care and erectile dysfunction, directly competing with the telehealth startup. \n</p>\n<p>\n     Amazon on Thursday launched the treatments through its One Medical telehealth service, and Amazon Prime members are eligible for free shipping, the company said. \n</p>\n<p>\n     Hims &amp; Hers's stock is down 25% in Thursday trading. Shares have more than doubled this year, due in part to the company's introduction of weight-loss treatments in May. Amazon's online pharmacy partnered with Lilly in March to fill prescriptions for the weight-loss drug Zepbound. \n</p>\n<p>\n     Hims &amp; Hers gained popularity as one of the first companies to directly ship hair and skin treatments to telehealth patients. The company said this month it had more than 2 million subscribers in the third quarter, a 40% boost from a year ago. \n</p>\n<p>\n     Amazon's push into low-cost treatments follows its launch of Haul, a budget online storefront similar to Temu or Shein. \n</p>\n<p>\n     Amazon said Prime members can access these treatments starting at: \n</p>\n<p>\n     -- Anti-aging skin-care: $10 a month \n</p>\n<p>\n     -- Men's hair loss: $16 a month \n</p>\n<p>\n     -- Erectile dysfunction treatment: $19 a month \n</p>\n<p>\n     -- Eyelash growth: $43 a month \n</p>\n<p>\n     -- Motion sickness treatment: $2 a month \n</p>\n<p>\n       This item is part of a Wall Street Journal live coverage event. The full stream can be found by searching P/WSJL (WSJ Live Coverage). \n</p>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  November 14, 2024 15:15 ET (20:15 GMT)\n</p>\n<p>\n  Copyright (c) 2024 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hims & Hers Stock Drops After Amazon Says It Will Offer Hair-Loss Treatments -- WSJ</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHims & Hers Stock Drops After Amazon Says It Will Offer Hair-Loss Treatments -- WSJ\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-15 04:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://dowjonesnews.com/newdjn/logon.aspx?AL=N><strong>Dow Jones</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>By Jasmine Li \n\n\n     Shares of Hims & Hers slid after Amazon.com said it would offer cheap treatments for concerns like hair loss, skin care and erectile dysfunction, directly competing with the ...</p>\n\n<a href=\"https://dowjonesnews.com/newdjn/logon.aspx?AL=N\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SG9999018857.SGD","symbol_name":"United Global Quality Growth Fd Cl Acc SGD-H","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2483331835","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2483331835","pubTimestamp":1731615300,"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Shares of Hims & Hers slid after Amazon.com said it would offer cheap treatments for concerns like hair loss, skin care and erectile dysfunction, directly competing with the telehealth startup.Amazon on Thursday launched the treatments through its One Medical telehealth service, and Amazon Prime members are eligible for free shipping, the company said.Hims & Hers's stock is down 25% in Thursday trading. Shares have more than doubled this year, due in part to the company's introduction of weight-loss treatments in May. Amazon's online pharmacy partnered with Lilly in March to fill prescriptions for the weight-loss drug Zepbound.Hims & Hers gained popularity as one of the first companies to directly ship hair and skin treatments to telehealth patients. The company said this month it had more than 2 million subscribers in the third quarter, a 40% boost from a year ago.Amazon's push into low-cost treatments follows its launch of Haul, a budget online storefront similar to Temu or Shein.Ama","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"SG9999018857.SGD":"United Global Quality Growth Fd Cl Acc SGD-H","LU0323591593.USD":"SCHRODER ISF QEP GLOBAL QUALITY \"A\" (USD) ACC","LU0672654240.SGD":"FTIF - Franklin US Opportunities A Acc SGD-H1","IE00BMPRXQ63.HKD":"NEUBERGER BERMAN NEXT GENERATION CONNECTIVITY FUND \"A\" (HKDHDG) ACC","LU1674673428.USD":"HSBC GIF GLOBAL LOWER CARBON EQUITY \"AC\" (USD) ACC","LU0211328371.USD":"TEMPLETON GLOBAL EQUITY INCOME \"A\" (MDIS) (USD)   INC","LU1116320737.USD":"BGF SYSTEMATIC GLOBAL ENHANCED EQUITY YIELD \"A6\" (USD) INC","SGXZ31699556.SGD":"UGDP UNITED GLOBAL QUALITY GROWTH \"C\" (SGDHDG) ACC","LU0211327993.USD":"TEMPLETON GLOBAL EQUITY INCOME \"A\" (USD) ACC","AMZN":"亚马逊","LU0345769631.USD":"NINETY ONE GSF GLOBAL EQUITY \"A\" (USD) INC","LU2552382058.USD":"WELLINGTON US BRAND POWER \"A\" (USD) ACC","LU2111349929.HKD":"ALLIANZ GLOBAL SUSTAINABILITY \"AM\" (HKD) INC","IE00BJTD4N35.SGD":"Neuberger Berman US Long Short Equity A1  Acc SGD-H","LU0882574139.USD":"富达环球消费行业基金A ACC","LU1066051225.USD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AC\" (USD) ACC","HIMS":"Hims & Hers Health Inc.","LU1244550494.USD":"FRANKLIN GLOBAL MULTI-ASSET INCOME \"A\" (USDHEDGED) ACC","IE00B7KXQ091.USD":"Janus Henderson Balanced A Inc USD","BK4566":"资本集团","LU2362541513.USD":"WELLINGTON NEXT GENERATION GLOBAL EQUITY \"A\" (USD) ACC","BK4524":"宅经济概念","IE0004086264.USD":"BNY MELLON GLOBAL OPPORTUNITIES \"A\" (USD) ACC","LU0943347566.SGD":"安联收益及增长平衡基金AM H2-SGD","LU1720051108.HKD":"ALLIANZ GLOBAL ARTIFICIAL INTELLIGENCE \"AT\" (HKD) ACC","LU2420271590.USD":"ALLIANZ SELECT INCOME AND GROWTH \"AT\" (USD) ACC","BK4559":"巴菲特持仓","LU0234570918.USD":"高盛全球核心股票组合Acc Close","LU2430703095.HKD":"WELLINGTON MULTI-ASSET HIGH INCOME \"AM4\" (HKD) INC","LU1988902786.USD":"FULLERTON LUX FUNDS GLOBAL ABSOLUTE ALPHA \"I\" (USD) ACC","IE00BJJMRX11.SGD":"Janus Henderson Balanced A Acc SGD","LU1548497426.USD":"安联环球人工智能AT Acc","SG9999015952.SGD":"LIONGLOBAL DISRUPTIVE INNOVATION \"I\" (SGD) ACC","LU2430703178.SGD":"WELLINGTON MULTI-ASSET HIGH INCOME \"AM4H\" (SGDHDG) INC","LU1366192091.USD":"ALLIANZ US EQUITY PLUS \"AM\" (USD) INC","SG9999001077.SGD":"United International Growth Fund SGD","LU2430703251.USD":"WELLINGTON MULTI-ASSET HIGH INCOME \"AM4\" (USD) INC","LU1935043536.SGD":"MANULIFE GF GLOBAL MULTI-ASSET DIVERSIFIED INCOME \"AA\" (SGDHDG) INC A","LU0056508442.USD":"贝莱德世界科技基金A2","LU1201861165.SGD":"Natixis Harris Associates Global Equity PA SGD","LU0964807845.USD":"ALLIANZ INCOME & GROWTH \"A\" (USD) INC","LU2265009873.SGD":"Eastspring Investments - Global Growth Equity AS SGD-H","IE00BJJMRY28.SGD":"Janus Henderson Balanced A Inc SGD","LU0267386448.USD":"FIDELITY FIRST ALL COUNTRY WORLD \"A\" (USD) INC","IE00BKDWB100.SGD":"PINEBRIDGE US LARGE CAP RESEARCH ENHANCED \"A5H\" (SGDHDG) ACC","LU1935042991.SGD":"MANULIFE GF GLOBAL MULTI-ASSET DIVERSIFIED INCOME  \"AA\" (SGDHDG) INC","LU2275660780.HKD":"SCHRODER ISF GLOBAL CLIMATE CHANGE EQUITY \"A\" (HKD) ACC","LU1633808545.USD":"ALLIANZ GLOBAL EQUITY GROWTH \"AT\" (USD) ACC","LU2756315664.SGD":"ALLIANZ INCOME AND GROWTH \"AMI\" (SGDHDG) INC","BK4548":"巴美列捷福持仓"},"translate_title":"亚马逊表示将提供脱发治疗后，Hims&Hers股价下跌——《华尔街日报》","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AMZN":1,"HIMS":0.9},"content_text":"By Jasmine Li \n\n\n     Shares of Hims & Hers slid after Amazon.com said it would offer cheap treatments for concerns like hair loss, skin care and erectile dysfunction, directly competing with the telehealth startup. \n\n\n     Amazon on Thursday launched the treatments through its One Medical telehealth service, and Amazon Prime members are eligible for free shipping, the company said. \n\n\n     Hims & Hers's stock is down 25% in Thursday trading. Shares have more than doubled this year, due in part to the company's introduction of weight-loss treatments in May. Amazon's online pharmacy partnered with Lilly in March to fill prescriptions for the weight-loss drug Zepbound. \n\n\n     Hims & Hers gained popularity as one of the first companies to directly ship hair and skin treatments to telehealth patients. The company said this month it had more than 2 million subscribers in the third quarter, a 40% boost from a year ago. \n\n\n     Amazon's push into low-cost treatments follows its launch of Haul, a budget online storefront similar to Temu or Shein. \n\n\n     Amazon said Prime members can access these treatments starting at: \n\n\n     -- Anti-aging skin-care: $10 a month \n\n\n     -- Men's hair loss: $16 a month \n\n\n     -- Erectile dysfunction treatment: $19 a month \n\n\n     -- Eyelash growth: $43 a month \n\n\n     -- Motion sickness treatment: $2 a month \n\n\n       This item is part of a Wall Street Journal live coverage event. The full stream can be found by searching P/WSJL (WSJ Live Coverage). \n\n\n  (END) Dow Jones Newswires\n\n\n  November 14, 2024 15:15 ET (20:15 GMT)\n\n\n  Copyright (c) 2024 Dow Jones & Company, Inc.","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[{"id":371288438358200,"gmtCreate":1731655796085,"gmtModify":1731655799927,"author":{"id":"4088945193415610","authorId":"4088945193415610","name":"judyspt","avatar":"https://static.tigerbbs.com/28075c7d730eb01e7fab4597684478f4","vip":1,"hat":"https://static.tigerbbs.com/6444b4970948c1077534c593eccd6d16","crmLevel":7,"crmLevelSwitch":1,"authorIdStr":"4088945193415610","idStr":"4088945193415610"},"htmlText":"Amazon wants to do everything will get backfire. Lost focus.&nbsp;","listText":"Amazon wants to do everything will get backfire. Lost focus.&nbsp;","text":"Amazon wants to do everything will get backfire. Lost focus.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/371288438358200","repostId":2483331835,"repostType":2,"repost":{"id":"2483331835","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1731615300,"share":"https://ttm.financial/m/news/2483331835?lang=&edition=fundamental","pubTime":"2024-11-15 04:15","market":"other","language":"en","title":"Hims & Hers Stock Drops After Amazon Says It Will Offer Hair-Loss Treatments -- WSJ","url":"https://stock-news.laohu8.com/highlight/detail?id=2483331835","media":"Dow Jones","summary":"Shares of Hims & Hers slid after Amazon.com said it would offer cheap treatments for concerns like hair loss, skin care and erectile dysfunction, directly competing with the telehealth startup.Amazon on Thursday launched the treatments through its One Medical telehealth service, and Amazon Prime members are eligible for free shipping, the company said.Hims & Hers's stock is down 25% in Thursday trading. Shares have more than doubled this year, due in part to the company's introduction of weight-loss treatments in May. Amazon's online pharmacy partnered with Lilly in March to fill prescriptions for the weight-loss drug Zepbound.Hims & Hers gained popularity as one of the first companies to directly ship hair and skin treatments to telehealth patients. The company said this month it had more than 2 million subscribers in the third quarter, a 40% boost from a year ago.Amazon's push into low-cost treatments follows its launch of Haul, a budget online storefront similar to Temu or Shein.Ama","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n       By Jasmine Li \n</p>\n<p>\n     Shares of Hims &amp; Hers slid after Amazon.com said it would offer cheap treatments for concerns like hair loss, skin care and erectile dysfunction, directly competing with the telehealth startup. \n</p>\n<p>\n     Amazon on Thursday launched the treatments through its One Medical telehealth service, and Amazon Prime members are eligible for free shipping, the company said. \n</p>\n<p>\n     Hims &amp; Hers's stock is down 25% in Thursday trading. Shares have more than doubled this year, due in part to the company's introduction of weight-loss treatments in May. Amazon's online pharmacy partnered with Lilly in March to fill prescriptions for the weight-loss drug Zepbound. \n</p>\n<p>\n     Hims &amp; Hers gained popularity as one of the first companies to directly ship hair and skin treatments to telehealth patients. The company said this month it had more than 2 million subscribers in the third quarter, a 40% boost from a year ago. \n</p>\n<p>\n     Amazon's push into low-cost treatments follows its launch of Haul, a budget online storefront similar to Temu or Shein. \n</p>\n<p>\n     Amazon said Prime members can access these treatments starting at: \n</p>\n<p>\n     -- Anti-aging skin-care: $10 a month \n</p>\n<p>\n     -- Men's hair loss: $16 a month \n</p>\n<p>\n     -- Erectile dysfunction treatment: $19 a month \n</p>\n<p>\n     -- Eyelash growth: $43 a month \n</p>\n<p>\n     -- Motion sickness treatment: $2 a month \n</p>\n<p>\n       This item is part of a Wall Street Journal live coverage event. The full stream can be found by searching P/WSJL (WSJ Live Coverage). \n</p>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  November 14, 2024 15:15 ET (20:15 GMT)\n</p>\n<p>\n  Copyright (c) 2024 Dow Jones &amp; Company, Inc.\n</p>\n</font>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hims & Hers Stock Drops After Amazon Says It Will Offer Hair-Loss Treatments -- WSJ</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHims & Hers Stock Drops After Amazon Says It Will Offer Hair-Loss Treatments -- WSJ\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2024-11-15 04:15</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n       By Jasmine Li \n</p>\n<p>\n     Shares of Hims &amp; Hers slid after Amazon.com said it would offer cheap treatments for concerns like hair loss, skin care and erectile dysfunction, directly competing with the telehealth startup. \n</p>\n<p>\n     Amazon on Thursday launched the treatments through its One Medical telehealth service, and Amazon Prime members are eligible for free shipping, the company said. \n</p>\n<p>\n     Hims &amp; Hers's stock is down 25% in Thursday trading. Shares have more than doubled this year, due in part to the company's introduction of weight-loss treatments in May. Amazon's online pharmacy partnered with Lilly in March to fill prescriptions for the weight-loss drug Zepbound. \n</p>\n<p>\n     Hims &amp; Hers gained popularity as one of the first companies to directly ship hair and skin treatments to telehealth patients. The company said this month it had more than 2 million subscribers in the third quarter, a 40% boost from a year ago. \n</p>\n<p>\n     Amazon's push into low-cost treatments follows its launch of Haul, a budget online storefront similar to Temu or Shein. \n</p>\n<p>\n     Amazon said Prime members can access these treatments starting at: \n</p>\n<p>\n     -- Anti-aging skin-care: $10 a month \n</p>\n<p>\n     -- Men's hair loss: $16 a month \n</p>\n<p>\n     -- Erectile dysfunction treatment: $19 a month \n</p>\n<p>\n     -- Eyelash growth: $43 a month \n</p>\n<p>\n     -- Motion sickness treatment: $2 a month \n</p>\n<p>\n       This item is part of a Wall Street Journal live coverage event. The full stream can be found by searching P/WSJL (WSJ Live Coverage). \n</p>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  November 14, 2024 15:15 ET (20:15 GMT)\n</p>\n<p>\n  Copyright (c) 2024 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SG9999018857.SGD":"United Global Quality Growth Fd Cl Acc SGD-H","LU0323591593.USD":"SCHRODER ISF QEP GLOBAL QUALITY \"A\" (USD) ACC","LU0672654240.SGD":"FTIF - Franklin US Opportunities A Acc SGD-H1","IE00BMPRXQ63.HKD":"NEUBERGER BERMAN NEXT GENERATION CONNECTIVITY FUND \"A\" (HKDHDG) ACC","LU1674673428.USD":"HSBC GIF GLOBAL LOWER CARBON EQUITY \"AC\" (USD) ACC","LU0211328371.USD":"TEMPLETON GLOBAL EQUITY INCOME \"A\" (MDIS) (USD)   INC","LU1116320737.USD":"BGF SYSTEMATIC GLOBAL ENHANCED EQUITY YIELD \"A6\" (USD) INC","SGXZ31699556.SGD":"UGDP UNITED GLOBAL QUALITY GROWTH \"C\" (SGDHDG) ACC","LU0211327993.USD":"TEMPLETON GLOBAL EQUITY INCOME \"A\" (USD) ACC","AMZN":"亚马逊","LU0345769631.USD":"NINETY ONE GSF GLOBAL EQUITY \"A\" (USD) INC","LU2552382058.USD":"WELLINGTON US BRAND POWER \"A\" (USD) ACC","LU2111349929.HKD":"ALLIANZ GLOBAL SUSTAINABILITY \"AM\" (HKD) INC","IE00BJTD4N35.SGD":"Neuberger Berman US Long Short Equity A1  Acc SGD-H","LU0882574139.USD":"富达环球消费行业基金A ACC","LU1066051225.USD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AC\" (USD) ACC","HIMS":"Hims & Hers Health Inc.","LU1244550494.USD":"FRANKLIN GLOBAL MULTI-ASSET INCOME \"A\" (USDHEDGED) ACC","IE00B7KXQ091.USD":"Janus Henderson Balanced A Inc USD","BK4566":"资本集团","LU2362541513.USD":"WELLINGTON NEXT GENERATION GLOBAL EQUITY \"A\" (USD) ACC","BK4524":"宅经济概念","IE0004086264.USD":"BNY MELLON GLOBAL OPPORTUNITIES \"A\" (USD) ACC","LU0943347566.SGD":"安联收益及增长平衡基金AM H2-SGD","LU1720051108.HKD":"ALLIANZ GLOBAL ARTIFICIAL INTELLIGENCE \"AT\" (HKD) ACC","LU2420271590.USD":"ALLIANZ SELECT INCOME AND GROWTH \"AT\" (USD) ACC","BK4559":"巴菲特持仓","LU0234570918.USD":"高盛全球核心股票组合Acc Close","LU2430703095.HKD":"WELLINGTON MULTI-ASSET HIGH INCOME \"AM4\" (HKD) INC","LU1988902786.USD":"FULLERTON LUX FUNDS GLOBAL ABSOLUTE ALPHA \"I\" (USD) ACC","IE00BJJMRX11.SGD":"Janus Henderson Balanced A Acc SGD","LU1548497426.USD":"安联环球人工智能AT Acc","SG9999015952.SGD":"LIONGLOBAL DISRUPTIVE INNOVATION \"I\" (SGD) ACC","LU2430703178.SGD":"WELLINGTON MULTI-ASSET HIGH INCOME \"AM4H\" (SGDHDG) INC","LU1366192091.USD":"ALLIANZ US EQUITY PLUS \"AM\" (USD) INC","SG9999001077.SGD":"United International Growth Fund SGD","LU2430703251.USD":"WELLINGTON MULTI-ASSET HIGH INCOME \"AM4\" (USD) INC","LU1935043536.SGD":"MANULIFE GF GLOBAL MULTI-ASSET DIVERSIFIED INCOME \"AA\" (SGDHDG) INC A","LU0056508442.USD":"贝莱德世界科技基金A2","LU1201861165.SGD":"Natixis Harris Associates Global Equity PA SGD","LU0964807845.USD":"ALLIANZ INCOME & GROWTH \"A\" (USD) INC","LU2265009873.SGD":"Eastspring Investments - Global Growth Equity AS SGD-H","IE00BJJMRY28.SGD":"Janus Henderson Balanced A Inc SGD","LU0267386448.USD":"FIDELITY FIRST ALL COUNTRY WORLD \"A\" (USD) INC","IE00BKDWB100.SGD":"PINEBRIDGE US LARGE CAP RESEARCH ENHANCED \"A5H\" (SGDHDG) ACC","LU1935042991.SGD":"MANULIFE GF GLOBAL MULTI-ASSET DIVERSIFIED INCOME  \"AA\" (SGDHDG) INC","LU2275660780.HKD":"SCHRODER ISF GLOBAL CLIMATE CHANGE EQUITY \"A\" (HKD) ACC","LU1633808545.USD":"ALLIANZ GLOBAL EQUITY GROWTH \"AT\" (USD) ACC","LU2756315664.SGD":"ALLIANZ INCOME AND GROWTH \"AMI\" (SGDHDG) INC","BK4548":"巴美列捷福持仓"},"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2483331835","content_text":"By Jasmine Li \n\n\n     Shares of Hims & Hers slid after Amazon.com said it would offer cheap treatments for concerns like hair loss, skin care and erectile dysfunction, directly competing with the telehealth startup. \n\n\n     Amazon on Thursday launched the treatments through its One Medical telehealth service, and Amazon Prime members are eligible for free shipping, the company said. \n\n\n     Hims & Hers's stock is down 25% in Thursday trading. Shares have more than doubled this year, due in part to the company's introduction of weight-loss treatments in May. Amazon's online pharmacy partnered with Lilly in March to fill prescriptions for the weight-loss drug Zepbound. \n\n\n     Hims & Hers gained popularity as one of the first companies to directly ship hair and skin treatments to telehealth patients. The company said this month it had more than 2 million subscribers in the third quarter, a 40% boost from a year ago. \n\n\n     Amazon's push into low-cost treatments follows its launch of Haul, a budget online storefront similar to Temu or Shein. \n\n\n     Amazon said Prime members can access these treatments starting at: \n\n\n     -- Anti-aging skin-care: $10 a month \n\n\n     -- Men's hair loss: $16 a month \n\n\n     -- Erectile dysfunction treatment: $19 a month \n\n\n     -- Eyelash growth: $43 a month \n\n\n     -- Motion sickness treatment: $2 a month \n\n\n       This item is part of a Wall Street Journal live coverage event. The full stream can be found by searching P/WSJL (WSJ Live Coverage). \n\n\n  (END) Dow Jones Newswires\n\n\n  November 14, 2024 15:15 ET (20:15 GMT)\n\n\n  Copyright (c) 2024 Dow Jones & Company, Inc.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":0,"commentSize":1,"repostSize":1,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2483331835"}